These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 36134433)

  • 1. Ventilated patient headboards in the postanesthesia care unit as an alternative to universal preprocedural severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing.
    Penney JA; Doron S
    Infect Control Hosp Epidemiol; 2023 Apr; 44(4):686-688. PubMed ID: 36134433
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among laboratory staff: Safe handling of coronavirus disease 2019 (COVID-19) samples.
    Hartard C; Agrinier N; Franck P; Prin-Mathieu C; Debourgogne A; Venard V; Schvoerer E; Jeulin H
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1738-1740. PubMed ID: 34287110
    [No Abstract]   [Full Text] [Related]  

  • 3. Universal admission testing with a rapid molecular point-of-care test and real-time polymerase chain reaction (PCR) assay for the detection of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Comparative performance and infection prevention implications.
    Mena Lora AJ; Chaisson LH; Wenzler E; Borgetti S; Bleasdale SC
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):138-140. PubMed ID: 36254755
    [No Abstract]   [Full Text] [Related]  

  • 4. The utility of paired upper and lower respiratory tract sampling for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in patients with artificial airways.
    Kitt EM; Davis DH; Kerman C; Sammons JS; Handy LK; Gallagher E; O'Callaghan K; Harris RM; Coffin SE; Bell LM; Chiotos K
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1482-1484. PubMed ID: 33966664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-based decision-making related to preprocedural coronavirus disease 2019 testing in the setting of GI endoscopy: management of risks, evidence, and behavioral health economics.
    Moy N; Dulleck U; Shah A; Messmann H; Thrift AP; Talley NJ; Holtmann GJ
    Gastrointest Endosc; 2022 Nov; 96(5):735-742.e3. PubMed ID: 35690149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Povidone-iodine preprocedural rinse-An evidence-based, second-line defense against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in dental healthcare.
    Maurya RK; Singh H; Kapoor P; Sharma P; Srivastava D
    Infect Control Hosp Epidemiol; 2022 Jun; 43(6):822-824. PubMed ID: 33706836
    [No Abstract]   [Full Text] [Related]  

  • 7. Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Testing Uptake in the Labor and Delivery Unit: Implications for Health Equity.
    Kernberg A; Kelly J; Nazeer S; Russell S; Tuuli M; Stout MJ; Raghuraman N; Carter EB
    Obstet Gynecol; 2020 Dec; 136(6):1103-1108. PubMed ID: 32858567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of cycle threshold values from severe acute respiratory coronavirus virus 2 (SARS-CoV-2) reverse-transcription polymerase chain reaction (RT-PCR) assays.
    Azeem A; Walters RW; Cavalieri SJ; Quimby DS
    Infect Control Hosp Epidemiol; 2023 Apr; 44(4):688-689. PubMed ID: 36524313
    [No Abstract]   [Full Text] [Related]  

  • 9. Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19.
    Xiao F; Sun J; Xu Y; Li F; Huang X; Li H; Zhao J; Huang J; Zhao J
    Emerg Infect Dis; 2020 Aug; 26(8):1920-1922. PubMed ID: 32421494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing High-risk Exposures for Healthcare Workers Through Universal Masking and Universal Severe Acute Respiratory Syndrome Coronavirus 2 Testing on Entry to a Tertiary Care Facility.
    Walker J; Fleece ME; Griffin RL; Leal SM; Alsip JA; Stigler WS; Nafziger SD; Marrazzo JM; Lee RA
    Clin Infect Dis; 2021 Nov; 73(9):e3113-e3115. PubMed ID: 32901247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy requirements of long-term ventilated COVID-19 patients with resolved SARS-CoV-2 infection.
    von Renesse J; von Bonin S; Held HC; Schneider R; Seifert AM; Seifert L; Spieth P; Weitz J; Welsch T; Meisterfeld R
    Clin Nutr ESPEN; 2021 Aug; 44():211-217. PubMed ID: 34330468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020.
    Scheier T; Schibli A; Eich G; Rüegg C; Kube F; Schmid A; Karrer U; Wolfensberger A; Sax H; Schreiber PW
    Emerg Infect Dis; 2021 Feb; 27(2):404-410. PubMed ID: 33395382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of coronavirus disease 2019 (COVID-19) infection control policies at leading US academic hospitals in the context of the initial pandemic surge of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant.
    Rhee C; Baker MA; Klompas M
    Infect Control Hosp Epidemiol; 2023 Apr; 44(4):597-603. PubMed ID: 35705223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area.
    Lewis SS; Smith BA; Akinboyo IC; Seidelman J; Wolfe C; Kirk AB; Martin G; Denny T; Lobaugh B; Rehder C; Cardona D; Lee MJ; Polage CR; Datto MB
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):341-343. PubMed ID: 32741409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retesting for severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Patterns of testing from a large US healthcare system.
    Kennedy AJ; Hilmes MK; Waddell L; Bartow AB; Baxter CM; Hadi CM; Snyder GM; Merlin JS
    Infect Control Hosp Epidemiol; 2021 Aug; 42(8):1023-1025. PubMed ID: 32772941
    [No Abstract]   [Full Text] [Related]  

  • 16. Surfaces and Air Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 Using High-Flow Nasal Oxygenation or Assisted Mechanical Ventilation in Intensive Care Unit Rooms of Patients With Coronavirus Disease 2019.
    Lebreil AL; Greux V; Glenet M; Huguenin A; N'Guyen Y; Berri F; Bajolet O; Mourvillier B; Andreoletti L
    J Infect Dis; 2022 Feb; 225(3):385-391. PubMed ID: 34788831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus Disease 2019 (COVID-19) Mitigation Efforts and Testing During an In-Person Training Event-Uganda, 12-29 October 2020.
    Laws RL; Biraro S; Kirungi W; Gianetti B; Aibo D; Awor AC; West C; Sachathep KK; Kiyingi H; Ward J; Mwangi C; Nkurunziza P; Okimait D; Currie D; Ajiboye A; Moore CS; Patel H; Sendagala S; Naluguza M; Mugisha V; Low A; Delgado S; Hoos D; Brown K; Galbraith JS; Hladik W; Nelson L; El-Sadr W; Musinguzi J; Voetsch AC
    Clin Infect Dis; 2021 Jul; 73(Suppl 1):S42-S44. PubMed ID: 33912911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining coronavirus disease 2019 (COVID-19) community incidence threshold for preoperative testing.
    Zhou J; Wituik C; Al-Salem M; Aljarbou A; Dekker J; Karimi S; Mertz D
    Infect Control Hosp Epidemiol; 2023 Jul; 44(7):1196-1198. PubMed ID: 35968708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Psychological Experience of Obstetric Patients and Health Care Workers after Implementation of Universal SARS-CoV-2 Testing.
    Bender WR; Srinivas S; Coutifaris P; Acker A; Hirshberg A
    Am J Perinatol; 2020 Oct; 37(12):1271-1279. PubMed ID: 32757185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission arising from a case of N-gene dropout on reverse-transcription polymerase chain reaction (RT-PCR) testing.
    Wee LEI; Ko KK; Conceicao EP; Aung MK; Aung MO; Yang Y; Arora S; Suphavilai C; Venkatachalam I
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):154-156. PubMed ID: 35775205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.